Annovis Bio annual current ratio
2019
2020
2021
2022
2023
2024
2025
Annovis Bio Current Ratio Growth & History (ANVS)
Annovis Bio's current ratio was 5.80 for fiscal 2025.
View full Annovis Bio company overviewAnnovis Bio annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 5.80 | 2.21 | +61.62% |
| 2024 | 2024-12-31 | 3.59 | 1.20 | +50.41% |
| 2023 | 2023-12-31 | 2.39 | −2.29 | −49.02% |
| 2022 | 2022-12-31 | 4.68 | −25.86 | −84.68% |
| 2021 | 2021-12-31 | 30.54 | 16.50 | +117.52% |
| 2020 | 2020-12-31 | 14.04 | 13.67 | +3676.13% |
| 2019 | 2019-12-31 | 0.37 | — | — |
Annovis Bio quarterly current ratio
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 3.47 | −4.18 | −54.69% |
| Q1 2026 | 2026-03-31 | 1.27 | −9.41 | −88.10% |
| Q4 2025 | 2025-12-31 | 5.80 | — | — |
| Q3 2025 | 2025-09-30 | 4.60 | — | — |
| Q2 2025 | 2025-06-30 | 7.65 | — | — |
| Q1 2025 | 2025-03-31 | 10.68 | 9.07 | +565.45% |
| Q1 2024 | 2024-03-31 | 1.60 | −3.12 | −66.02% |
| Q4 2023 | 2023-12-31 | 2.39 | −2.29 | −49.02% |
| Q3 2023 | 2023-09-30 | 2.87 | −11.82 | −80.48% |
| Q2 2023 | 2023-06-30 | 11.00 | −19.76 | −64.23% |
| Q1 2023 | 2023-03-31 | 4.72 | −26.84 | −85.04% |
| Q4 2022 | 2022-12-31 | 4.68 | −25.86 | −84.68% |
| Q3 2022 | 2022-09-30 | 14.69 | −27.83 | −65.45% |
| Q2 2022 | 2022-06-30 | 30.76 | −25.23 | −45.06% |
| Q1 2022 | 2022-03-31 | 31.56 | 27.83 | +744.87% |
| Q4 2021 | 2021-12-31 | 30.54 | 16.50 | +117.52% |
| Q3 2021 | 2021-09-30 | 42.52 | 9.07 | +27.11% |
| Q2 2021 | 2021-06-30 | 55.99 | 41.47 | +285.79% |
| Q1 2021 | 2021-03-31 | 3.74 | −11.53 | −75.53% |
| Q4 2020 | 2020-12-31 | 14.04 | 13.67 | +3676.13% |
| Q3 2020 | 2020-09-30 | 33.45 | — | — |
| Q2 2020 | 2020-06-30 | 14.51 | — | — |
| Q1 2020 | 2020-03-31 | 15.27 | — | — |
| Q4 2019 | 2019-12-31 | 0.37 | — | — |
Annovis Bio current ratio trends
Over the last five fiscal years, Annovis Bio's current ratio decreased from 14.04 to 5.80, a change of −8.24. The latest reported quarter, Q2 2026, shows 3.47.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Annovis Bio source filings ↗